Cargando…
Evaluation of the effect of ambrisentan on digital microvascular flow in patients with systemic sclerosis using laser Doppler perfusion imaging: a 12-week randomized double-blind placebo controlled trial
INTRODUCTION: In patients with systemic sclerosis (SSc), digital ischemia results from an occlusive microvasculopathy that may not respond adequately to conventional vasodilators. Endothelin receptor antagonists can potentially modify the fibroproliferative vascular remodeling in SSc, and hence thei...
Autores principales: | Bose, Nilanjana, Bena, James, Chatterjee, Soumya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384235/ https://www.ncbi.nlm.nih.gov/pubmed/25876611 http://dx.doi.org/10.1186/s13075-015-0558-9 |
Ejemplares similares
-
Decreased digital skin microvascular blood flow before and after cold stimulus using Laser Doppler imaging in juvenile systemic sclerosis
por: RATerreri, Maria Teresa, et al.
Publicado: (2011) -
Repeatability of the evaluation of systemic microvascular endothelial function using laser doppler perfusion monitoring: clinical and statistical implications
por: Tibiriçá, Eduardo, et al.
Publicado: (2011) -
A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome
por: Mohammed, Shaadab, et al.
Publicado: (2021) -
Ambrisentan for the treatment of pulmonary arterial hypertension
por: Casserly, Brian, et al.
Publicado: (2009) -
Ambrisentan-induced severe asymptomatic thrombocytopenia
por: Kigitovica, Dana, et al.
Publicado: (2020)